Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution...
Reexamination Certificate
2006-08-18
2010-11-23
Leith, Patricia (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
C424S776000
Reexamination Certificate
active
07838045
ABSTRACT:
The subject of this invention is the anti-inflammatory activity of a formulation ofBarbarea verna(upland cress, early winter cress, or winter cress) seed preparation (BSP) containing phenethylisothiocyanate as its main active ingredient. BSP is a promising anti-inflammatory agent, which can be used for treatment of many inflammation-related conditions, including but not limited to rheumatoid and osteoarthritis, acute and chronic pains, lupus, irritable bowl disease, cancer and metabolic syndrome.
REFERENCES:
patent: 5589154 (1996-12-01), Anderson
patent: 6348220 (2002-02-01), Ribnicky et al.
patent: 2002/0061352 (2002-05-01), Ekanayake et al.
Vickers et a.: A Vaccine Vagainst Alzheimer'S Disease.: Drugs Aging.: 2002. 19 (7) pp. 487-494.
Clohisy et al.: Direct Inhibition of NF-Kb Blocks Bone Erosion Associated With Inflammatory Arthritis.: The Journal of Immunology.: 2003. 171: 5547-5553.
Gerhauser et al.: Mechanism-Based In Vitro Screening of Potential Cancer Chemopreventive Agents.: Mutation Research.: 523-524. 2003. 163-172.
Krakauer. Molecular Therapeutic Targets in Inflammation: Cyclooxygenase and NF-kB. Current Drug Targets-Inflammation & Allergy. 2004. 3. pp. 317-324.
Rose et al., B-Phenylethyl and 8-methylsulphinyloctyl isothiocyanates, constituents of watercress, suppress LPS induces production of nitric oxide and prostaglandin E2 in RAW 264.7 macrophages, Nitric Oxide, Jun. 2005, vol. 12 No. 4 pp. 237-243, especially p. 237 and p. 240.
Krakauer, T., “Molecular Therapeutic Targets in Inflammation: Cyclooxygenase and NF-kappaB”, Current Drug Targets—Inflammation & Allergy, vol. 3, pp. 317-324, (2004).
Heiss et al., “Nuclear Factor kappaB Is a Molecular Target for Sulforaphane-mediated Anti-inflammatory Mechanism”, The Journal of Biological Chemistry, vol. 276, No. 34, pp. 32008-32015, (2001).
Sporn et al., “Peptide Growth Factors and Inflammation, Tissue Repair, and Cancer”, The Journal of Clinical Investigation, vol. 78, pp. 329-332, (1986).
Hooper et al., “Prevention of Experimental Allergic Encephalomyelitis by Targeting Nitric Oxide and Peroxynitrite: Implications for the Treatment of Multiple Sclerosis”, PNAS, vol. 94, No. 6, pp. 2528-2533, (1997).
Simonian et al., “Oxidative Stress in Neurodegenerative Diseases”, Annual Review, vol. 36, pp. 83-106, (1996).
Hantraye et al., “Inhibition of Neuronal Nitric Oxide Synthase Prevents MPTP-induced Parkinsonism in Baboons”, Nature Medicine, vol. 2, No. 9, pp. 1017-1021, (1996).
Ohshima et al., “Chronic Infections and Inflammatory Processes as Cancer Risk Factors: Possible Role of Nitric Oxide in Carcinogenesis”, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 305, Issue 2, pp. 253-264, (1994).
Esposito et al., “The Metabolic Syndrome and Inflammation: Association or Causation?”, Nutr. Metab. Cardiovasc. Dis.,vol. 14, pp. 228-232, (2004).
Stoewsand, G.S., “Bioactive Organosulfur Phytochemicals in Brassica oleracea Vegetables—A Review”, Fd. Chem. Toxic, vol. 33, No. 6, pp. 537-543, (1995).
Chen et al., “Suppression of Inducible Nitric Oxide Production by Indole and Isothiocyanate Derivatives from BrassicaPlants in Stimulated Macrophages” , Planta Med, vol. 69, pp. 696-700, (2003).
Gerhauser et al., “Mechanism-based In Vitro Screening of Potential Cancer Chemopreventive Agents”, Mutation Research, vols. 523-524, pp. 163-172, (2003).
Martin et al., “Protective Effect of the Interleukin-1 Receptor Antagonist (IL-Ira) on Experimental Allergic Encephalomyelitis in Rats”, Journal of Neuroimmunology, vol. 61, pp. 241-245, (1995).
Brooks, P., “Use and Benefits of Nonsterodial Anti-Inflammatory Drugs”, Am. J. Med., vol. 3A, pp. 9S-13S, (1998).
Baldwin, Jr., A.S., “The NF-kappaB and IkappaB Proteins: New Discoveries and Insights”, Annu. Rev. Immunol., vol. 14, pp. 649-681, (1996).
Baum, et al., “Utilization of Nonsteroidal Antiinflammatory Drugs”, Arthritis & Rheumatism, vol. 26, Issue 6, pp. 686-692, (1985).
Pathak et al., “Oxidative Stress and Cyclooxygenase Activity in Prostate Carcinogenesis: Targets for Chemopreventive Strategies”, European Journal of Cancer, vol. 41, pp. 61-70, (2005).
Bombardier et al., “Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis”, The New England Journal of Medicine, pp. 1520-1528, (2000).
Juni et al., “COX 2 Inhibitors, Traditional NSAIDs, and the Heart” ,BMJ, 330: pp. 1342-1343, (2005).
Ribnicky et al., “Seed ofBarbarea vernaas a Rich Source of Phenethyl Isothiocyanate to Provide Natural Protection from Environmental and Dietary Toxins”, Journal of Nutraceuticals, Functional & Medical Foods, vol. 3, No. 3, pp. 43-65, (2001).
Harris et al., “Comparative Effects of Phenethylisothiocyanate (PEITC) and an Extract of Upland Cress (Barbarea verna) Seed on Intestinal Tumorigenesis In Vivo”, Abstract for the Annual Meeting of the American Association for Cancer Research, Anaheim, California, (2005).
Mosmann, T., “Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays”, Journal of Immunological Methods, vol. 65, pp. 55-63, (1983).
von Knethen et al., “Superinduction of Cyclooxygenase-2 by NO and Agonist Challenge Involves Transcriptional Regulation Mediated by AP-1 Activation”, Biochemistry, vol. 39, pp. 1532-1540, (2000).
von Knethen et al.., “NF-kappaB and AP-1 Activation by Nitric Oxide Attenuated Apoptotic Cell Death in RAW 264.7 Macrophages”, Molecular Biology of the Cell, vol. 10, pp. 361-372, (1999).
Wu et al., “Hypoxia Induces Myocyte-dependent COX-2 Regulation in Endothelial Cells” Role of VEGF, Am. J. Physiol. Heart Circ. Physiol, vol. 285, pp. H2420-H2429, (2003).
Baeuerie et al., “NF-kappaB: Ten Years After”, Cell, vol. 87, pp. 13-20, (1996).
Yamamoto et al., “Role of the NF-kappaB Pathway in the Pathogenesis of Human Disease States”, Current Molecular Medicine, vol. 1, pp. 287-296, (2001).
Oshima et al., “Suppression of Intestinal Polyposis in Apc 716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)”, Cell, vol. 87, pp. 803-809, (1996).
Kwon et al., “Effects of Aspirin on Nitric Oxide Formation and De Novo Protein Synthesis by RINm5F Cells and Rat islets”, Molecular Pharmacology, vol. 52, pp. 398-405, (1997).
Pfaffl, M.W., “A New Mathematical Model for Relative Quantification in Real-time RT-PCT”, Nucleic Acids Research, vol. 29, No. 9, pp. 2002-2007, (2001).
Rodriguez et al., “Risk of Upper Gastrointestinal Bleeding and Perforation Associated with Individual Non-steroidal Anti-inflammatory Drugs”, The Lancet, vol. 343, Issue 8900, pp. 769-772, (1994).
Sheng et al., “Modulation of Apoptosis and Bc1-2 Expression by Prostaglandin E2 in Human Colon Cancer Cells”, Cancer Research, vol. 58, pp. 362-366, (1998).
Steinbach et al., “The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, In Familial Adenomatous Polyposis”, The New England Journal of Medicine, vol. 342, No. 26, pp. 1946-1952, (2000).
Subbaramaiah et al., “Inhibition of Cyclooxygenase: A Novel Approach to Cancer Prevention”, Experimental biology and Medicine, vol. 216, pp. 201-210, (1997).
Takahashi et al., “Increased Expression of Inducible and Endothelial Constitutive Nitric Oxide Synthases in Rat Colon Tumors Induced by Azoxymethane”, Cancer Research, vol. 57, pp. 1233-1237, (1997).
Karin et al., “Phosphorylation Meets Ubiquitination: The Control of NF-kappaB Activity”, Annual Review of Immunology, vol. 18, pp. 621-663, (2000).
Graziewicz et al., “Nitric Oxide Inhibits DNA Ligase Activity: Potential Mechanisms for NO-Mediated DNA Damage”, Carcinogenesis, vol. 1
Dey Moul
Raskin Ilya
Ribnicky David M.
Leith Patricia
Marshall & Gerstein & Borun LLP
McCormick Melenie
LandOfFree
Anti-inflammatory activity of phenethylisothiocyanate... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-inflammatory activity of phenethylisothiocyanate..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-inflammatory activity of phenethylisothiocyanate... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4230455